Specimens of all labeling which has not been previously submitted during the PMTA, prior postmarket reviews, or below portion 905(i) in the FD&C Act and descriptions of all labeling changes including the day the labeling was very first disseminated along with the day when dissemination was absolutely terminated.FDA is proposing to need data concern